Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. [electronic resource]
Producer: 20050726Description: 1217-24 p. digitalISSN:- 1538-4047
- Adenocarcinoma -- blood supply
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Apoptosis -- drug effects
- Celecoxib
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- therapeutic use
- Dinoprostone -- metabolism
- Endothelial Cells -- metabolism
- Fibroblast Growth Factor 2 -- metabolism
- Group IV Phospholipases A2
- Humans
- Indomethacin -- therapeutic use
- Interleukin-8 -- metabolism
- Male
- Membrane Proteins
- Mice
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Pancreatic Neoplasms -- blood supply
- Phospholipases A -- metabolism
- Phospholipases A2
- Prostaglandin-Endoperoxide Synthases -- metabolism
- Pyrazoles -- therapeutic use
- Sulfonamides -- therapeutic use
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factor A -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.